IL139936A0 - Gene therapy method - Google Patents

Gene therapy method

Info

Publication number
IL139936A0
IL139936A0 IL13993699A IL13993699A IL139936A0 IL 139936 A0 IL139936 A0 IL 139936A0 IL 13993699 A IL13993699 A IL 13993699A IL 13993699 A IL13993699 A IL 13993699A IL 139936 A0 IL139936 A0 IL 139936A0
Authority
IL
Israel
Prior art keywords
gene therapy
therapy method
gene
therapy
Prior art date
Application number
IL13993699A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811836.7A external-priority patent/GB9811836D0/en
Priority claimed from GBGB9815035.2A external-priority patent/GB9815035D0/en
Priority claimed from GBGB9819846.8A external-priority patent/GB9819846D0/en
Priority claimed from GBGB9828578.6A external-priority patent/GB9828578D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL139936A0 publication Critical patent/IL139936A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13993699A 1998-06-02 1999-06-02 Gene therapy method IL139936A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9811836.7A GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method
GBGB9815035.2A GB9815035D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819846.8A GB9819846D0 (en) 1998-09-12 1998-09-12 Gene therapy method
GBGB9828578.6A GB9828578D0 (en) 1998-12-23 1998-12-23 Regulation
PCT/GB1999/001722 WO1999062561A2 (en) 1998-06-02 1999-06-02 Gene therapy method

Publications (1)

Publication Number Publication Date
IL139936A0 true IL139936A0 (en) 2002-02-10

Family

ID=27451790

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13993699A IL139936A0 (en) 1998-06-02 1999-06-02 Gene therapy method

Country Status (29)

Country Link
US (1) US6689758B1 (de)
EP (2) EP1083934B1 (de)
JP (1) JP2002516676A (de)
KR (1) KR20010043968A (de)
CN (1) CN1311822A (de)
AP (1) AP2000001999A0 (de)
AT (1) ATE246518T1 (de)
AU (1) AU770497B2 (de)
BR (1) BR9910877A (de)
CA (1) CA2334171A1 (de)
DE (1) DE69910202T2 (de)
DK (1) DK1083934T3 (de)
EA (1) EA200001124A1 (de)
EE (1) EE200000790A (de)
ES (1) ES2205830T3 (de)
HK (1) HK1034465A1 (de)
HR (1) HRP20000832A2 (de)
HU (1) HUP0103252A3 (de)
ID (1) ID27483A (de)
IL (1) IL139936A0 (de)
IS (1) IS5742A (de)
NO (1) NO20006047L (de)
NZ (1) NZ508505A (de)
PL (1) PL345207A1 (de)
PT (1) PT1083934E (de)
SK (1) SK18322000A3 (de)
TR (2) TR200100348T2 (de)
WO (1) WO1999062561A2 (de)
YU (1) YU75600A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
AU2003202489A1 (en) * 2002-01-10 2003-07-30 Takeda Chemical Industries, Ltd. Screening method
WO2004060476A2 (en) * 2002-12-31 2004-07-22 The Johns Hopkins University Wound healing method and kits
CA2537184A1 (en) * 2003-08-29 2005-03-10 Anges Mg, Inc. Gene therapy for skin disorders using needleless syringes
DE10342071B4 (de) * 2003-09-10 2006-01-19 Fleischmann, Wilhelm, Dr.med. Vorrichtung und Verfahren zur Applikation von Wïrkstoffen an eine Wundoberfläche
KR100647490B1 (ko) 2004-10-04 2006-11-23 사회복지법인 삼성생명공익재단 저산소 조건 및 다른 스트레스에 특이적으로 반응할 수있는 키메라 인핸서 요소를 포함하는 벡터, 상기 벡터를포함하는 약제학적 조성물 및 상기 조성물을 이용하는 방법
WO2008141308A2 (en) 2007-05-11 2008-11-20 Adynxx, Inc. Gene expression and pain
FR2920158B1 (fr) * 2007-08-24 2010-03-12 Centre Nat Rech Scient Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
FR2924128A1 (fr) * 2007-11-26 2009-05-29 Galderma Res & Dev Modulateurs de egr1 dans le traitement de l'alopecie
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
CN102552938A (zh) * 2012-03-22 2012-07-11 南京大学 Egr-1拮抗剂在制备治疗Ⅱ型糖尿病的药物中的用途
CN104487096B (zh) 2012-05-10 2020-09-15 埃迪恩克斯股份有限公司 用于活性成分递送的配制物
ES2750689T3 (es) 2014-08-15 2020-03-26 Adynxx Inc Señuelos oligonucleotídicos para el tratamiento del dolor
KR101721228B1 (ko) * 2015-04-03 2017-03-30 사회복지법인 삼성생명공익재단 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
CN104857529A (zh) * 2015-05-20 2015-08-26 山西大学 Egr-1基因在制备抗膀胱癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763209A (en) 1988-09-26 1998-06-09 Arch Development Corporation Methods and materials relating to the functional domains of DNA binding proteins
US5206152A (en) * 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
AUPN855496A0 (en) 1996-03-07 1996-04-04 Unisearch Limited Prevention of proliferation of vascular cells

Also Published As

Publication number Publication date
JP2002516676A (ja) 2002-06-11
ES2205830T3 (es) 2004-05-01
ID27483A (id) 2001-04-12
DE69910202D1 (de) 2003-09-11
EP1083934A2 (de) 2001-03-21
TR200100348T2 (tr) 2001-07-23
AU4156099A (en) 1999-12-20
HUP0103252A3 (en) 2003-09-29
NZ508505A (en) 2003-04-29
HK1034465A1 (en) 2001-10-26
US6689758B1 (en) 2004-02-10
CN1311822A (zh) 2001-09-05
PT1083934E (pt) 2003-12-31
YU75600A (sh) 2004-03-12
NO20006047L (no) 2001-02-01
AP2000001999A0 (en) 2000-12-31
PL345207A1 (en) 2001-12-03
WO1999062561A2 (en) 1999-12-09
EE200000790A (et) 2002-04-15
DK1083934T3 (da) 2003-12-01
EP1281763A3 (de) 2003-07-09
KR20010043968A (ko) 2001-05-25
SK18322000A3 (sk) 2001-11-06
NO20006047D0 (no) 2000-11-29
EP1281763A2 (de) 2003-02-05
HUP0103252A2 (hu) 2001-12-28
WO1999062561A3 (en) 2000-08-03
IS5742A (is) 2000-11-28
AU770497B2 (en) 2004-02-26
BR9910877A (pt) 2002-01-22
ATE246518T1 (de) 2003-08-15
TR200102985T2 (tr) 2002-06-21
CA2334171A1 (en) 1999-12-09
DE69910202T2 (de) 2004-06-17
EA200001124A1 (ru) 2001-08-27
HRP20000832A2 (en) 2001-04-30
EP1083934B1 (de) 2003-08-06

Similar Documents

Publication Publication Date Title
GB9622500D0 (en) Therapeutic gene
EP1077996A4 (de) Menschliches edg3sb-gen
PL345207A1 (en) Gene therapy method
GB9816556D0 (en) Therapy
HUP0104046A3 (en) Adenovirus-mediated gene therapy
GB9719161D0 (en) New therapeutic method
GB9714841D0 (en) Treatment method
GB0025890D0 (en) Gene therapy
GB9802475D0 (en) Method
GB9900009D0 (en) Gene therapy
GB9814989D0 (en) Gene therapy method
GB9819846D0 (en) Gene therapy method
GB9819826D0 (en) Gene therapy method
GB9815035D0 (en) Gene therapy method
GB9811836D0 (en) Gene therapy method
GB9706469D0 (en) Genetic method
GB0406539D0 (en) Gene therapy
GB9719176D0 (en) New therapeutic method
GB9719189D0 (en) New therapeutic method
GB9804285D0 (en) Therapeutic method
GB9800683D0 (en) Therapeutic method
GB9806039D0 (en) Therapy
GB9826753D0 (en) Genetic method
GB9818001D0 (en) Genetic method
GB9719163D0 (en) New therapeutic method